Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amandine Maulard

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Bulletin Du Cancer|November 14, 2024
[Practical application of the 2023 FIGO classification for endometrial cancer]Solène Grosse, Catherine Genestie, Stéphanie Scherier, et al.
BMC Cancer|February 7, 2021
False negative rate at <sup>18</sup>F-FDG PET/CT in para-aortic lymphnode involvement in patients with locally advanced cervical cancer: impact of PET technologySebastien Gouy, Veronika Seebacher, Cyrus Chargari, et al.
Gynecologic Oncology Reports|October 4, 2017
Staging surgery in early-stage ovarian mucinous tumors according to expansile and infiltrative typesSebastien Gouy, Marine Saidani, Amandine Maulard, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 16, 2022
Safety of direct oral anticoagulants in patients with advanced solid tumors receiving anti-VEGF agents: a retrospective studyAlice Boileve, Laurence Albiges, Michel Ducreux, et al.
Gynecologic Oncology Reports|October 13, 2017
Is uterine preservation combined with bilateral salpingo-oophorectomy to promote subsequent fertility safe in infiltrative mucinous ovarian cancer?Sebastien Gouy, Marine Saidani, Amandine Maulard, et al.
Bulletin Du Cancer|March 2, 2023
[Current post-surgical treatment strategies in first-line ovarian cancer]Kaïssa Ouali, Judith Michels, Felix Blanc-Durand, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 14, 2024
Correlation between peritoneal cancer index and survival in advanced epithelial ovarian cancer with complete resectionClaire Sanson, Alice Roosen, Matthieu Faron, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Correlation between peritoneal cancer index and survival in advanced epithelial ovarian cancer with complete resectionClaire Sanson, Alice Roosen, Matthieu Faron, et al.
Gynecologic Oncology|November 9, 2020
Distribution of novel immune-checkpoint targets in ovarian cancer tumor microenvironment: A dynamic landscapeFélix Blanc-Durand, Catherine Genestie, Elisa Yaniz Galende, et al.
Cancers|March 21, 2020
Changes in DNA Damage Response Markers with Treatment in Advanced Ovarian CancerPaul Kubelac, Catherine Genestie, Aurelie Auguste, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Bulletin Du Cancer|November 14, 2024
[Practical application of the 2023 FIGO classification for endometrial cancer]Solène Grosse, Catherine Genestie, Stéphanie Scherier, et al.
BMC Cancer|February 7, 2021
False negative rate at <sup>18</sup>F-FDG PET/CT in para-aortic lymphnode involvement in patients with locally advanced cervical cancer: impact of PET technologySebastien Gouy, Veronika Seebacher, Cyrus Chargari, et al.
Gynecologic Oncology Reports|October 4, 2017
Staging surgery in early-stage ovarian mucinous tumors according to expansile and infiltrative typesSebastien Gouy, Marine Saidani, Amandine Maulard, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 16, 2022
Safety of direct oral anticoagulants in patients with advanced solid tumors receiving anti-VEGF agents: a retrospective studyAlice Boileve, Laurence Albiges, Michel Ducreux, et al.
Gynecologic Oncology Reports|October 13, 2017
Is uterine preservation combined with bilateral salpingo-oophorectomy to promote subsequent fertility safe in infiltrative mucinous ovarian cancer?Sebastien Gouy, Marine Saidani, Amandine Maulard, et al.
Bulletin Du Cancer|March 2, 2023
[Current post-surgical treatment strategies in first-line ovarian cancer]Kaïssa Ouali, Judith Michels, Felix Blanc-Durand, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 14, 2024
Correlation between peritoneal cancer index and survival in advanced epithelial ovarian cancer with complete resectionClaire Sanson, Alice Roosen, Matthieu Faron, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Correlation between peritoneal cancer index and survival in advanced epithelial ovarian cancer with complete resectionClaire Sanson, Alice Roosen, Matthieu Faron, et al.
Gynecologic Oncology|November 9, 2020
Distribution of novel immune-checkpoint targets in ovarian cancer tumor microenvironment: A dynamic landscapeFélix Blanc-Durand, Catherine Genestie, Elisa Yaniz Galende, et al.
Cancers|March 21, 2020
Changes in DNA Damage Response Markers with Treatment in Advanced Ovarian CancerPaul Kubelac, Catherine Genestie, Aurelie Auguste, et al.
Pageof 4